Back to the Future: So What Will Fibrinolytic Therapy Offer Your Patients with Myocardial Infarction?

Overview

Journal Br Med J (Clin Res Ed)

Specialty General Medicine

Date 1986 Apr 12

PMID 3083976

Citations 1

Authors

J R Mitchell

Affiliations

Soon will be listed here.

Citing Articles

Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.

Hillis W, Hornung R, Hogg K, Hockings N, Burns J, Dunn F Drugs. 1987; 33 Suppl 3:117-23.

PMID: 3315576 DOI: 10.2165/00003495-198700333-00019.

References

Gaffney P . Thrombosis: a molecular approach to therapy. Nature. 1981; 290(5806):445-6. DOI: 10.1038/290445a0. View

Sherry S, Fletcher A, ALKJAERSIG N . Fibrinolysis and fibrinolytic activity in man. Physiol Rev. 1959; 39(2):343-82. DOI: 10.1152/physrev.1959.39.2.343. View

Mitchell J . "But will it help my patients with myocardial infarction?" The implications of recent trials for everyday country folk. Br Med J (Clin Res Ed). 1982; 285(6349):1140-8. PMC: 1500166. DOI: 10.1136/bmj.285.6349.1140. View

Schroder R, Biamino G, von Leitner E, Linderer T, Bruggemann T, Heitz J . Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation. 1983; 67(3):536-48. DOI: 10.1161/01.cir.67.3.536. View

Khaja F, Walton Jr J, Brymer J, Lo E, Osterberger L, ONeill W . Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med. 1983; 308(22):1305-11. DOI: 10.1056/NEJM198306023082201. View

Anderson J, MARSHALL H, Bray B, Lutz J, FREDERICK P, Yanowitz F . A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med. 1983; 308(22):1312-8. DOI: 10.1056/NEJM198306023082202. View

Rogers W, MANTLE J, Hood Jr W, Baxley W, Whitlow P, Reeves R . Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction. Circulation. 1983; 68(5):1051-61. DOI: 10.1161/01.cir.68.5.1051. View

Kennedy J, Ritchie J, Davis K, Fritz J . Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med. 1983; 309(24):1477-82. DOI: 10.1056/NEJM198312153092402. View

Van de Werf F, Ludbrook P, Bergmann S, Tiefenbrunn A, Fox K, De Geest H . Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. N Engl J Med. 1984; 310(10):609-13. DOI: 10.1056/NEJM198403083101001. View

10.

Anderson J, MARSHALL H, Askins J, Lutz J, Sorensen S, Menlove R . A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction. Circulation. 1984; 70(4):606-18. DOI: 10.1161/01.cir.70.4.606. View

11.

Collen D, Stassen J, Marafino Jr B, Builder S, De Cock F, Ogez J . Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells. J Pharmacol Exp Ther. 1984; 231(1):146-52. View

12.

Collen D, Topol E, Tiefenbrunn A, Gold H, WEISFELDT M, Sobel B . Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. Circulation. 1984; 70(6):1012-7. DOI: 10.1161/01.cir.70.6.1012. View

13.

Tiefenbrunn A, Robinson A, Kurnik P, Ludbrook P, Sobel B . Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology. Circulation. 1985; 71(1):110-6. DOI: 10.1161/01.cir.71.1.110. View

14.

Rentrop K . Thrombolytic therapy in patients with acute myocardial infarction. Circulation. 1985; 71(4):627-31. DOI: 10.1161/01.cir.71.4.627. View

15.

Verstraete M, Bernard R, BORY M, Brower R, Collen D, De Bono D . Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. Lancet. 1985; 1(8433):842-7. DOI: 10.1016/s0140-6736(85)92208-1. View

16.

Kennedy J, Ritchie J, Davis K, Stadius M, Maynard C, Fritz J . The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. N Engl J Med. 1985; 312(17):1073-8. DOI: 10.1056/NEJM198504253121701. View

17.

Davies M, Thomas A . Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985; 53(4):363-73. PMC: 481773. DOI: 10.1136/hrt.53.4.363. View

18.

Agnelli G, Buchanan M, Fernandez F, Boneu B, Van Ryn J, Hirsh J . A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. Circulation. 1985; 72(1):178-82. DOI: 10.1161/01.cir.72.1.178. View

19.

Simoons M, Serruys P, vd Brand M, Bar F, de Zwaan C, Res J . Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet. 1985; 2(8455):578-82. DOI: 10.1016/s0140-6736(85)90584-7. View

20.

Yusuf S, Collins R, Peto R, Furberg C, Stampfer M, Goldhaber S . Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J. 1985; 6(7):556-85. DOI: 10.1093/oxfordjournals.eurheartj.a061905. View